<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Causes of wide QRS complex tachycardia in children</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Causes of wide QRS complex tachycardia in children</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Causes of wide QRS complex tachycardia in children</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan P Etheridge, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John K Triedman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 19, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Wide QRS tachycardia may be due to ventricular tachycardia (VT), supraventricular tachycardia (SVT) with aberrant conduction, or atrioventricular reentrant tachycardia (AVRT) with an accessory pathway. Children with wide QRS complex tachycardia may present with hemodynamic instability, and if not urgently treated, serious morbidity or death may occur. (See  <a class="medical medical_review" href="/z/d/html/6392.html" rel="external">"Pediatric advanced life support (PALS)"</a>.)</p><p>Causes of wide QRS complex tachycardia in children will be reviewed here. The evaluation and management of wide QRS complex tachycardia in children are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5758.html" rel="external">"Management and evaluation of wide QRS complex tachycardia in children"</a>.)</p><p class="headingAnchor" id="H4203566463"><span class="h1">DEFINITIONS</span><span class="headingEndMark"> — </span>The following terms are used throughout this topic:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tachycardia</strong> – Tachycardia in children is generally defined as a heart rate above the normal range for age (ie, &gt;160 beats per minute for infants under age 2, &gt;140 beats per minute for children 2 to 12 years, and &gt;100 beats per minute for adolescents and adults  (<a class="graphic graphic_table graphicRef77057" href="/z/d/graphic/77057.html" rel="external">table 1</a>))</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Wide QRS complex</strong> – Wide QRS complex is defined by a QRS duration &gt;80 milliseconds in younger children and &gt;100 milliseconds in adolescents</p><p></p><p class="headingAnchor" id="H2"><span class="h1">SUPRAVENTRICULAR TACHYCARDIA</span><span class="headingEndMark"> — </span>Supraventricular tachycardia (SVT) originates above the ventricles and usually presents as a narrow QRS complex tachycardia. However, SVT can also produce a wide QRS complex through the following mechanisms:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Aberrant conduction</strong> – Conduction through the His-Purkinje system can be delayed or blocked, which results in a wide QRS complex. (See  <a class="medical medical_review" href="/z/d/html/2101.html" rel="external">"Basic approach to delayed intraventricular conduction"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atrioventricular reentrant tachycardia (AVRT) with an accessory pathway</strong> – AVRT requires the presence of an extranodal accessory pathway connecting the atrium and ventricle. This allows direct electrical communication between the two chambers.</p><p></p><p class="bulletIndent1">During AVRT tachycardia, QRS complexes can be either narrow or wide depending upon the direction of conduction through the reentrant pathway. If the ventricles are activated antegrade via the accessory pathway, followed by retrograde conduction over the atrioventricular node/His-Purkinje system, the QRS complex will be wide. This is known as antidromic reciprocating tachycardia  (<a class="graphic graphic_waveform graphicRef54484" href="/z/d/graphic/54484.html" rel="external">waveform 1</a> and <a class="graphic graphic_waveform graphicRef71410" href="/z/d/graphic/71410.html" rel="external">waveform 2</a>).</p><p></p><p class="bulletIndent1">In the more common orthodromic form with a narrow QRS complex, the ventricles are activated antegrade through the atrioventricular node, followed by retrograde conduction back to the atria via the accessory pathway.</p><p></p><p class="bulletIndent1">SVT is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/5783.html" rel="external">"Clinical features and diagnosis of supraventricular tachycardia (SVT) in children"</a>.)</p><p></p><p class="headingAnchor" id="H3"><span class="h1">VENTRICULAR TACHYCARDIA</span><span class="headingEndMark"> — </span>Ventricular tachycardia (VT) originates from the ventricular myocardium or Purkinje cells below the bifurcation of the bundle of His. It is reported to occur in 3 percent of healthy children [<a href="#rid1">1,2</a>].</p><p>VT may be associated with sudden cardiac death. As a result, patients who develop VT or are at risk for developing VT must be identified, evaluated, and treated if necessary. Some forms of VT found primarily in infants and young children may be benign, but this conclusion is reached only after other more serious causes of VT are excluded. (See  <a class="medical medical_review" href="/z/d/html/85989.html" rel="external">"Sudden cardiac arrest (SCA) and sudden cardiac death (SCD) in children"</a>.)</p><p>VT is defined as three or more consecutive beats of ventricular origin on electrocardiogram (ECG). It can occur in patients with congenital heart disease (CHD), an inherited disorder that affects cardiac electrical or myocardial function, acquired heart disease, or in the setting of a structurally and functionally normal heart.</p><p>In one retrospective review from a single Swiss center, 27 children with spontaneous episodes of VT were observed from 1995 to 2005: 13 had no structural heart disease, and the remaining 14 patients had a wide range of underlying cardiac disease [<a href="#rid3">3</a>]. Five patients died, all of whom had underlying cardiac disease.</p><p>In a school-based screening study from Japan, resting ECGs demonstrated an incidence of VT at 2 to 8 per 100,000 children [<a href="#rid4">4</a>]. Among the 48 children with VT detected on screening ECG, two had structural heart disease and the other 46 patients had idiopathic ventricular tachycardia.</p><p class="headingAnchor" id="H4"><span class="h2">Congenital heart disease</span><span class="headingEndMark"> — </span>Arrhythmias, including VT, are seen as a late complication in children and adults with CHD. This finding is associated with increased risk of mortality and serious morbidity. The electrical pathophysiology in CHD is based upon a complex interplay between gross cardiac anatomy, chamber enlargement from abnormal pressure and volume loads, cellular injury from hypoxia and cardiopulmonary bypass, fibrosis at the site of suture lines, and direct trauma to the specialized conduction tissues [<a href="#rid5">5</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – In general, the risk of experiencing VT among patients with CHD increases with age. Onset of arrhythmic complications of CHD most commonly occurs in adulthood. Other factors that influence the risk of VT in this setting include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>The nature of the specific CHD defect</strong> – Ventricular arrhythmias are a leading cause of morbidity and mortality in patients with CHD as they reach adulthood. VT is most frequently associated with tetralogy of Fallot (TOF), although it may occur in patients with other congenital defects (eg, D-transposition of the great arteries, Ebstein malformation of the tricuspid valve, and lesions with left ventricular outflow obstruction) [<a href="#rid5">5-9</a>]. VT risk is possibly highest in adults with a baffle palliation for D-transposition of the great arteries [<a href="#rid10">10</a>]. Most studies of VT and CHD focus on a specific lesion and often favor the study of more common lesions with a surgical outcome good enough to provide reasonable patient numbers. Thus, many studies focus on TOF [<a href="#rid11">11</a>]. (See  <a class="medical medical_review" href="/z/d/html/141526.html" rel="external">"Tetralogy of Fallot (TOF): Long-term complications and follow-up after repair", section on 'Arrhythmias and sudden cardiac death'</a>.)</p><p></p><p class="bulletIndent2">After surgical repair of TOF, the incidences of VT and sudden cardiac death have been reported to be as high as 12 and 8 percent, respectively [<a href="#rid12">12</a>]. The origin of VT is primarily at the site of surgical repair. Although less common, ventricular arrhythmias have been seen in patients with CHD who have not undergone intracardiac surgical repair, suggesting that surgical scar is not the only substrate for VT [<a href="#rid5">5,13</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Residual cardiac defects after repair</strong> – In individuals with repaired or palliated CHD including TOF, the presence of residual cardiac defects, volume overload, or cardiac dysfunction has been associated with an increased risk of VT [<a href="#rid14">14</a>]. In adults with repaired TOF, left ventricular failure has been associated with sudden death following surgical repair [<a href="#rid15">15</a>]. In fact, moderate to severe left ventricular systolic dysfunction on echocardiogram has proven to be a stronger predictor of serious cardiac events than any right ventricular variable [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Widened QRS postoperatively</strong> – Several studies have also reported that postoperative patients with a QRS duration that is greater than or equal to 180 milliseconds were more likely to develop VT or sudden cardiac death [<a href="#rid15">15-17</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other factors</strong> – Other reported risk factors for VT following surgical repair for TOF include older age at repair and increased length of time from repair [<a href="#rid15">15</a>], a history of palliative shunts, inducible VT at electrophysiology (EP) testing, and high-grade ventricular ectopy [<a href="#rid5">5</a>]. A later age at repair seems to correlate with the development of left ventricular dysfunction, possibly due to prolonged periods of time with ventricular volume overload and hypoxia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presentation</strong> – Although patients may experience slow VT and are hemodynamically stable at presentation, some patients present with rapid VT that results in syncope or cardiac arrest. Ventricular arrhythmias are the most common cause of sudden death in patients following surgical repair for TOF; however, atrial arrhythmias and atrioventricular block may also have catastrophic outcomes in adults with CHD, including death [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/z/d/html/141526.html" rel="external">"Tetralogy of Fallot (TOF): Long-term complications and follow-up after repair", section on 'Management of VT and prevention of SCD'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>EP testing</strong> – EP testing with programmed ventricular stimulation is useful in identifying postoperative patients with CHD who are at increased risk of developing serious arrhythmias, including VT. The induction of VT at EP testing is an imperfect but powerful predictor, independent of ECG and other clinical variables [<a href="#rid18">18</a>]. </p><p></p><p class="bulletIndent1">This was illustrated in a study of 252 postoperative patients with TOF (mean age 16 years) who had programmed ventricular stimulation at the time of EP testing [<a href="#rid9">9</a>]. Sustained monomorphic VT was induced in 30 percent and polymorphic VT in 4.4 percent of patients. There was a threefold increase in the incidence of symptomatic VT or sudden death in patients with a positive EP study compared with those with a negative study. </p><p></p><p class="bulletIndent1">In a study of 452 patients with repaired TOF who underwent pulmonary valve replacement (PVR) and were followed for a median of 6.5 years, 6 percent died and an additional 2 percent experienced resuscitated sudden cardiac arrest or sustained VT [<a href="#rid19">19</a>]. Independent predictors of death or adverse outcome included age ≥28 years at time of PVR, preoperative right ventricular ejection fraction &lt;40 percent, right ventricular mass-to-volume ratio ≥0.45 g/mL, and right ventricular systolic pressure ≥40 mmHg. (See  <a class="medical medical_review" href="/z/d/html/141526.html" rel="external">"Tetralogy of Fallot (TOF): Long-term complications and follow-up after repair", section on 'Pulmonary valve replacement (PVR)'</a>.)</p><p></p><p>The management of VT in patients with CHD is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5758.html" rel="external">"Management and evaluation of wide QRS complex tachycardia in children", section on 'Patients with underlying congenital heart disease'</a>.)</p><p class="headingAnchor" id="H6"><span class="h2">Genetic disorders</span><span class="headingEndMark"> — </span>With molecular genetic advances, several genetic disorders that are associated with VT have been identified. They can be classified as channelopathies or cardiomyopathic disorders.</p><p class="headingAnchor" id="H7"><span class="h3">Channelopathy</span><span class="headingEndMark"> — </span>Inherited channelopathies associated with VT are briefly reviewed here and are discussed individually in detail separately. These disorders affect the movement of ions (eg, sodium, potassium, and calcium) through channels within the cardiac cell membrane and include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Long QT syndrome (LQTS)</strong> – LQTS is a disorder of myocardial repolarization characterized by a prolonged QT interval and T-wave abnormalities on the ECG, syncope, and sudden cardiac death.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Variants in a number of cardiac ion genes and genes that affect ion channel function have been identified in patients with congenital LQTS  (<a class="graphic graphic_table graphicRef114927" href="/z/d/graphic/114927.html" rel="external">table 2</a>); most patients have a loss of function of a potassium channel (eg, <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F607542&amp;token=G%2BkOOgscg7PQzd0gXq5S9%2BkOaTxqZ7hgoL07BXslEDPCr6ds8XKnQHG9jFELFTYX&amp;TOPIC_ID=5786" target="_blank">KCNQ1</a><em> </em>and <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F152427&amp;token=G%2BkOOgscg7PQzd0gXq5S95OQ04nkXyc%2Fcrq69lxXddourmWMLJZtxaPRpbON0Fu7&amp;TOPIC_ID=5786" target="_blank">KCNH2</a>) or a gain of function of a sodium channel (eg, <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F600163&amp;token=G%2BkOOgscg7PQzd0gXq5S96JfoAtdEPXTlP%2F636bpIflmJNl6FJm1iToqDYkQb5fR&amp;TOPIC_ID=5786" target="_blank">SCN5A</a>). The clinical phenotypes of congenital LQTS include the common autosomal dominant form and the autosomal recessive form (<a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F220400&amp;token=G%2BkOOgscg7PQzd0gXq5S93Qd15TexDOqtSZYnOGluWDFcm6juRGoAHX1gQeslvZs&amp;TOPIC_ID=5786" target="_blank">Jervell and Lange-Nielsen syndrome</a>), which is also associated with sensorineural deafness and has a more malignant clinical course. Other rare forms of LQTS include <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F601005&amp;token=G%2BkOOgscg7PQzd0gXq5S9%2FOUAi4NDcBUotLP4lmH5DSRXsg1Fb7htt6Gb5YYPum0&amp;TOPIC_ID=5786" target="_blank">Timothy syndrome</a> (characterized by profound QT prolongation, structural cardiac disease, and noncardiac manifestations) [<a href="#rid20">20</a>] and <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F170390&amp;token=G%2BkOOgscg7PQzd0gXq5S9z9wZCdCrt%2FRnoAi4t1ZHtEVQ93zf8dt8QC7t0jfC5qd&amp;TOPIC_ID=5786" target="_blank">Andersen-Tawil syndrome</a> (characterized by LQTS, noncardiac features, and periodic paralysis) [<a href="#rid21">21</a>]. The genetics and diagnosis of congenital LQTS are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/1009.html" rel="external">"Congenital long QT syndrome: Pathophysiology and genetics"</a> and  <a class="medical medical_review" href="/z/d/html/1053.html" rel="external">"Congenital long QT syndrome: Diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>LQTS is associated with an increased risk of a life-threatening arrhythmia referred to as torsades de pointes  (<a class="graphic graphic_waveform graphicRef73827" href="/z/d/graphic/73827.html" rel="external">waveform 3</a>). Causes of acquired prolonged QTc duration (eg, drugs, hypokalemia, and hypomagnesemia) can also precipitate ventricular arrhythmia in patients with congenital LQTS  (<a class="graphic graphic_table graphicRef57431" href="/z/d/graphic/57431.html" rel="external">table 3</a>). (See <a class="local">'Acquired heart disease'</a> below and  <a class="medical medical_review" href="/z/d/html/1043.html" rel="external">"Acquired long QT syndrome: Definitions, pathophysiology, and causes"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with LQTS may present with syncope, seizures, or cardiac arrest. A family history of sudden death, seizures, recurrent syncope, or unexplained drowning should heighten the suspicion of LQTS. A link between LQTS and sudden infant death syndrome (SIDS) has been reported, though it likely accounts for a very small subset of SIDS cases [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/z/d/html/1036.html" rel="external">"Congenital long QT syndrome: Epidemiology and clinical manifestations"</a> and  <a class="medical medical_review" href="/z/d/html/6366.html" rel="external">"Sudden infant death syndrome: Risk factors and risk reduction strategies", section on 'Genetic factors'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The mortality rate in LQTS is reduced with earlier identification of affected patients and treatment, including beta blocker therapy, sports modification in some, and avoidance of medications known to lengthen the QTc interval  (<a class="graphic graphic_table graphicRef57431" href="/z/d/graphic/57431.html" rel="external">table 3</a>). High-risk patients including those with syncope or torsades de pointes despite beta blocker therapy may benefit from an implantable cardioverter defibrillator (ICD) or left cardiac sympathetic denervation (LCSD). The strict sports restrictions previously applied to all patients with LQTS should be tailored to the patient and to his/her genotypic and phenotypic expression of the disease, and a shared decision-making approach is advocated. Physical exertion (particularly swimming) appears to be a common trigger for ventricular arrhythmias in LQT1, whereas individuals with LQT2 seem more at risk for auditory or emotional triggers, as well as postpartum events. Patients with LQT3 may be at greater risk during periods of rest and during times when the heart rate is slow  (<a class="graphic graphic_figure graphicRef64239" href="/z/d/graphic/64239.html" rel="external">figure 1</a>). However, exceptions to these genotype-phenotype correlations hinder genotype-specific tailoring of recommendations. The genotype and phenotype, as well as family and patient considerations, must be considered before any eligibility or disqualification decision is rendered [<a href="#rid23">23</a>]. An ongoing prospective research study is assessing the risk of death, cardiac arrest, ventricular arrhythmias, or syncope in individuals with LQTS who are participating in moderate or vigorous exercise and in sedentary individuals [<a href="#rid24">24</a>]. Management of congenital LQTS is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/988.html" rel="external">"Congenital long QT syndrome: Treatment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Brugada syndrome</strong> – Brugada syndrome, first described in 1992 [<a href="#rid25">25</a>], is an uncommon channelopathy. Brugada syndrome is associated with characteristic ECG findings of ST segment elevation in leads V1 to V3 and a right bundle branch block-like pattern in the right precordial leads, which can be triggered by the fever  (<a class="graphic graphic_waveform graphicRef64510" href="/z/d/graphic/64510.html" rel="external">waveform 4</a> and <a class="graphic graphic_waveform graphicRef100119" href="/z/d/graphic/100119.html" rel="external">waveform 5</a>) and certain drugs including cannabis. (See  <a class="medical medical_review" href="/z/d/html/1020.html" rel="external">"Brugada syndrome: Epidemiology and pathogenesis", section on 'Fever'</a>.)</p><p></p><p class="bulletIndent1">Brugada syndrome is characterized by variable expression. <em>SCN5A</em> gene variants, which encode for the subunit of a cardiac sodium channel, resulting in a loss of sodium channel function, have been found in 10 to 30 percent of patients with Brugada syndrome. It is likely that in many patients, Brugada syndrome is an oligogenic disease and that the coinheritance of several genetic risk variants contribute to the disease [<a href="#rid26">26</a>]. (See  <a class="medical medical_review" href="/z/d/html/1020.html" rel="external">"Brugada syndrome: Epidemiology and pathogenesis", section on 'Genetics'</a>.)</p><p></p><p class="bulletIndent1">Affected patients may present with life-threatening ventricular arrhythmias. Sudden cardiac death may be the first and only clinical event in Brugada syndrome, occurring in as many as one-third of patients. Death usually occurs during sleep and in the early morning hours. A family history of sudden death at a young age is commonly found. In some patients, the typical ECG findings of Brugada are present intermittently but may be unmasked by fever, increased core body temperature, or the administration of medications.</p><p></p><p class="bulletIndent1">The clinical features, diagnosis, and management of Brugada syndrome are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/106759.html" rel="external">"Brugada syndrome: Clinical presentation, diagnosis, and evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Catecholaminergic polymorphic VT (CPVT)</strong> – Patients with CPVT are at risk for VT (specifically, bidirectional VT), supraventricular arrhythmias, ventricular fibrillation, and sudden cardiac death, especially in association with adrenergic stress or exercise  (<a class="graphic graphic_waveform graphicRef76976" href="/z/d/graphic/76976.html" rel="external">waveform 6</a>). Like LQT1, there are increasing data to suggest that some drowning and near-drowning events and sudden infant death syndrome are associated with CPVT [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1">At rest, the ECG typically is normal, although bradycardia and a prominent U wave have been reported. With adrenergic influence, there is the appearance of frequent premature ventricular contractions (PVCs) and nonsustained polymorphic VT. The ventricular ectopy is described as bidirectional. The QT interval is normal, which distinguishes it from LQTS, and there are no ST segment changes differentiating it from Brugada syndrome.</p><p></p><p class="bulletIndent1">This disorder is inherited in an autosomal dominant or autosomal recessive pattern and also occurs in sporadic cases as a de novo mutation. Various variants of gene loci that encode proteins involved in calcium regulation across the sarcoplasmic reticulum have been identified in patients with CPVT. These include mutations of the <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F180902&amp;token=G%2BkOOgscg7PQzd0gXq5S9wqw1z%2BuvTpyl9IMEsLmS0iY9y17qFuGhzQyzxdzCaQ6&amp;TOPIC_ID=5786" target="_blank">RyR2</a> gene (which encodes the human cardiac ryanodine receptor) and the calsequestrin 2 gene (which encodes a major calcium reservoir protein within the sarcoplasmic reticulum). Mutations in the <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F114180&amp;token=G%2BkOOgscg7PQzd0gXq5S9zvDuZKLmUzb1%2B4hX%2B9Bb0kT52cJz685YHqr1gs6dAjp&amp;TOPIC_ID=5786" target="_blank">CALM1</a> gene, which encodes calmodulin, result in compromised calcium binding and have been associated with familial ventricular fibrillation and sudden cardiac death [<a href="#rid28">28,29</a>].</p><p></p><p class="bulletIndent1">CPVT is typically a disease of childhood and adolescence, but it can present at any age. One possible explanation for the peak in childhood/adolescence is that the intensity of exercise and physical activity is typically higher at this age compared with infancy and later adulthood. Approximately 30 percent of patients have a family history of sudden death in childhood and adolescence. Prognosis is guarded, even in patients in whom the disease is identified and treatment instituted. The mainstay of therapy includes beta blockers, with emerging encouraging results from <a class="drug drug_pediatric" data-topicid="13302" href="/z/d/drug information/13302.html" rel="external">flecainide</a>. There are increasing data about the superiority of <a class="drug drug_pediatric" data-topicid="12625" href="/z/d/drug information/12625.html" rel="external">nadolol</a> over other beta blockers for CPVT [<a href="#rid30">30</a>]. ICD or LCSD have been used for high-risk patients and those with symptoms despite medical therapy. The emerging recognition of the risk of ICD storm in this population is negatively influencing the decision for ICD implantation in children with CPVT. LCSD has proven an effective antifibrillatory intervention for these patients. Whenever syncope occurs despite optimal medical therapy, LCSD could be considered the next step rather than an ICD and could complement the ICD in patients with recurrent shocks [<a href="#rid31">31</a>]. These therapies and the clinical features of CPVT are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/916.html" rel="external">"Catecholaminergic polymorphic ventricular tachycardia"</a>.)</p><p></p><p class="headingAnchor" id="H8"><span class="h3">Cardiomyopathy</span><span class="headingEndMark"> — </span>VT can often be associated with inherited cardiomyopathic disorders and, less commonly, with more generalized inherited myopathic diseases, such as myotonic dystrophy. (See  <a class="medical medical_review" href="/z/d/html/5147.html" rel="external">"Myotonic dystrophy: Etiology, clinical features, and diagnosis", section on 'Cardiac abnormalities'</a>.)</p><p>The following is a brief review of the inherited cardiomyopathies associated with ventricular arrhythmias, which are discussed in greater detail separately.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypertrophic cardiomyopathy</strong> – Hypertrophic cardiomyopathy remains the most common cause of sport-related sudden death in young people in the United States. It is a genetic disease of the cardiac sarcomere that is caused by variants in one of more than 50 genes that encode most, if not all, of the myocardial contractile proteins. This leads to wide variation in the clinical presentation and course of this disorder and makes standardization of therapy difficult.</p><p></p><p class="bulletIndent1">Genetic testing, clinical manifestations, and treatment of patients with hypertrophic cardiomyopathy are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4951.html" rel="external">"Hypertrophic cardiomyopathy in children: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/4956.html" rel="external">"Hypertrophic cardiomyopathy: Gene mutations and clinical genetic testing"</a> and  <a class="medical medical_review" href="/z/d/html/4916.html" rel="external">"Hypertrophic cardiomyopathy: Natural history and prognosis"</a>.)</p><p></p><p class="bulletIndent1">In patients with hypertrophic cardiomyopathy, ventricular arrhythmias are thought to be due to electrically unstable myocardium resulting from myocellular disarray, fibrosis, and ischemia. Ventricular arrhythmias and sudden cardiac arrest in hypertrophic cardiomyopathy are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/4952.html" rel="external">"Hypertrophic cardiomyopathy: Risk stratification for sudden cardiac death"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Arrhythmogenic cardiomyopathy (ACM)</strong> – ACM is defined by a clinical presentation with documented or symptomatic arrhythmia and myocardial structural and functional abnormalities. Arrhythmogenic right ventricular cardiomyopathy (ARVC) is the best characterized of the ACMs. ARVC is a characterized by fatty or fibrofatty replacement of the right ventricular myocardium, resulting in myocardial thinning, aneurysm formation, and wall motion abnormalities. In some cases, there may also be left ventricle involvement, with relative sparing of the ventricular septum.</p><p></p><p class="bulletIndent1">ARVC was thought to be rare but is now thought to account for 3 to 5 percent of unexplained sudden deaths in adolescents and young adults and up to 11 percent in northern Italy. Both autosomal dominant and recessive forms of ARVC have been reported, with identified variants in several desmosomal protein genes. Autosomal recessive ARVC is less common and can be part of a syndrome called Naxos disease, which also includes hyperkeratosis of the palms and soles and wooly hair. (See  <a class="medical medical_review" href="/z/d/html/4929.html" rel="external">"Arrhythmogenic right ventricular cardiomyopathy: Pathogenesis and genetics", section on 'Genetics'</a>.)</p><p></p><p class="bulletIndent1">Affected patients generally present between 10 and 50 years of age with dizziness, palpitations, and syncope due to VT. The characteristic VT has a left bundle branch pattern that should lead one to consider a right ventricular origin.</p><p></p><p class="bulletIndent1">Physiologic cardiac adaptation to regular exercise, including biventricular dilation and T-wave inversion, may create diagnostic overlap with ARVC [<a href="#rid32">32,33</a>]. The T-wave changes and balanced biventricular dilation are thought likely to represent benign manifestations of training in asymptomatic athletes without relevant family history. Diagnostic criteria for ARVC were nonspecific in such individuals, and comprehensive testing using widely available techniques may be needed to differentiate these entities.</p><p></p><p class="bulletIndent1">Other ECG findings of ARVC as well as the clinical findings, diagnostic evaluation, and treatment of ARVC are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/4932.html" rel="external">"Arrhythmogenic right ventricular cardiomyopathy: Treatment and prognosis"</a> and  <a class="medical medical_review" href="/z/d/html/4931.html" rel="external">"Arrhythmogenic right ventricular cardiomyopathy: Anatomy, histology, and clinical manifestations"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Duchenne muscular dystrophy</strong> – With improved management, patients with Duchenne muscular dystrophy are surviving into their 20s, and cardiomyopathy is emerging as a cause of morbidity and mortality. Heart failure and associated fibrosis in patients with Duchenne muscular dystrophy predisposes patients to ventricular arrhythmias, which is associated with a risk of sudden cardiac death [<a href="#rid34">34,35</a>]. (See  <a class="medical medical_review" href="/z/d/html/6149.html" rel="external">"Duchenne and Becker muscular dystrophy: Clinical features and diagnosis", section on 'Cardiomyopathy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Barth syndrome</strong> – Barth syndrome is an X-linked disorder characterized by a noncompaction of the left ventricle, a form of a dilated cardiomyopathy, cyclic neutropenia, skeletal myopathy, and growth delay. Ventricular arrhythmias and sudden death can occur in this population, and monitoring for this should be undertaken in these patients [<a href="#rid36">36</a>]. (See  <a class="medical medical_review" href="/z/d/html/4912.html" rel="external">"Inherited syndromes associated with cardiac disease", section on 'Barth syndrome'</a>.)</p><p></p><p class="headingAnchor" id="H9"><span class="h2">Acquired heart disease</span><span class="headingEndMark"> — </span>Acquired heart diseases that can result in VT in children include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Coronary heart disease</strong> – In contrast to adults, VT is rarely caused by coronary heart disease in children. Structural coronary artery abnormalities (eg, left coronary arising from the right sinus) are an important cause of arrhythmic sudden death in the young, especially in association with sports [<a href="#rid37">37</a>]. (See  <a class="medical medical_review" href="/z/d/html/1060.html" rel="external">"Ventricular arrhythmias during acute myocardial infarction: Incidence, mechanisms, and clinical features"</a> and  <a class="medical medical_review" href="/z/d/html/1536.html" rel="external">"Congenital and pediatric coronary artery abnormalities"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Myocarditis</strong> – Viral infections of the myocardium cause myocardial inflammation and may be associated with ventricular ectopy, complex VT, heart failure, and sudden death. Viral myocarditis is increasingly recognized as a contributor to unexplained mortality and a cause of sudden cardiac death in the first two decades of life. Myocardial inflammation, ion channel dysfunction, and EP and structural remodeling may play important roles in generating life-threatening arrhythmias in myocarditis patients. Mechanisms of arrhythmia are thought to be both triggered activity and reentry [<a href="#rid38">38</a>]. Host-mediated and viral-induced inflammation can promote arrhythmogenesis by inducing ion channel abnormalities and cardiac remodeling. </p><p></p><p class="bulletIndent1">Acute myocarditis and ventricular arrhythmias can occur in severe COVID-19, as discussed separately. (See  <a class="medical medical_review" href="/z/d/html/127551.html" rel="external">"COVID-19: Arrhythmias and conduction system disease"</a>.)</p><p></p><p class="bulletIndent1">The clinical manifestations, diagnosis, and treatment of myocarditis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5755.html" rel="external">"Clinical manifestations and diagnosis of myocarditis in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chagas disease</strong> – Chagas disease is caused by the parasite <em>Trypanosoma</em> <em>cruzi</em>, which resides primarily in Central and South America. Although uncommon in children, dilated cardiomyopathy can develop and is associated with heart failure, heart block, and VT during the chronic phase of the infection. (See  <a class="medical medical_review" href="/z/d/html/4955.html" rel="external">"Chronic Chagas cardiomyopathy: Clinical manifestations and diagnosis", section on 'Arrhythmias'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acquired QTc prolongation</strong> – Like congenital LQTS, patients with acquired QTc prolongation are at risk for developing polymorphic VT. QTc prolongation can be caused by the following  (<a class="graphic graphic_table graphicRef57431" href="/z/d/graphic/57431.html" rel="external">table 3</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Metabolic disturbances – Hypokalemia, hypomagnesemia, or anorexia nervosa. (See  <a class="medical medical_review" href="/z/d/html/14705.html" rel="external">"Anorexia nervosa in adults and adolescents: Medical complications and their management", section on 'Cardiovascular'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Myocardial infarction or ischemia.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intracranial disease – Stroke.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Drugs – Antiarrhythmic drugs (eg, <a class="drug drug_pediatric" data-topicid="12755" href="/z/d/drug information/12755.html" rel="external">quinidine</a> or <a class="drug drug_pediatric" data-topicid="12732" href="/z/d/drug information/12732.html" rel="external">procainamide</a>), some nonsedating antihistamines (eg, terfenadine or astemizole), macrolide antibiotics, antipsychotic and antidepressant medications, <a class="drug drug_pediatric" data-topicid="12659" href="/z/d/drug information/12659.html" rel="external">ondansetron</a>, and <a class="drug drug_pediatric" data-topicid="12590" href="/z/d/drug information/12590.html" rel="external">methadone</a>.</p><p></p><p class="bulletIndent1">The clinical features, diagnosis, and management of acquired QTc prolongation are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/116011.html" rel="external">"Acquired long QT syndrome: Clinical manifestations, diagnosis, and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiac tumors</strong> – Rarely, VT may be caused by primary cardiac tumors. In a retrospective study of 173 children with primary cardiac tumors (including 106 rhabdomyomas, 25 fibromas, 14 myxomas, 6 vascular malformations, 4 teratomas, 3 lipomas, and 15 other tumors), approximately one-quarter had clinically significant arrhythmias, with VT being the most common [<a href="#rid39">39</a>]. VT was particularly common in patients with fibromas, occurring in two-thirds of that subset. Approximately one-third of the entire cohort (62 patients) underwent surgical excision, and control of arrhythmia was an indication for surgery in 20 patients. Postoperatively, arrhythmias resolved in 18 of these 20 patients. In a later study from the same group that included 18 children with VT due to cardiac fibromas, sustained arrhythmia episodes were found to correlate with diffuse myocyte interdigitation and entrapped myocardium [<a href="#rid40">40</a>]. All four patients who underwent complete tumor resection were cured of arrhythmias. However, 2 of the 14 with subtotal resections had recurrence. These findings suggest that the interdigitating myocardium represents a potential histopathologic substrate for VT.</p><p></p><p class="headingAnchor" id="H10"><span class="h2">Idiopathic causes</span><span class="headingEndMark"> — </span>Relatively benign forms of VT can be seen in children without demonstrable pathology. They include accelerated ventricular rhythm, right ventricular outflow tract (RVOT) tachycardia, and left VT.</p><p class="headingAnchor" id="H11"><span class="h3">Accelerated ventricular rhythm</span><span class="headingEndMark"> — </span>It is important to differentiate accelerated ventricular rhythm from VT because the prognosis is different. Accelerated ventricular rhythm is a relatively slow monomorphic ventricular rhythm. The rate tends to be just slightly faster than the sinus rate (15 to 20 percent faster) and so varies with age, but most often it is &lt;120 beats per minute [<a href="#rid41">41</a>]. Although most commonly seen in newborns, accelerated ventricular rhythm may be present in older children and adolescents [<a href="#rid42">42,43</a>].</p><p>Accelerated ventricular rhythm is distinguished from VT because of its slower rate and the absence of symptoms. In addition, accelerated ventricular rhythm is usually suppressed by exertion, whereas VT from other causes may persist or degenerate into ventricular fibrillation during exercise, and/or results in progressive myocardial dysfunction over time. Accelerated ventricular rhythm is generally diagnosed only in patients with a structurally and functionally normal heart, although rare cases have been seen in children with CHD [<a href="#rid44">44</a>].</p><p>The ECG typically shows sinus rhythm followed by fusion beats at the onset of the ventricular rhythm and at its termination. The EP mechanism is unknown and may include triggered activity or abnormal automaticity.</p><p>Accelerated ventricular rhythm is usually a benign condition that often occurs in newborn infants [<a href="#rid45">45</a>]. It most often resolves spontaneously and should not be treated [<a href="#rid45">45</a>]. Thus, it is important to differentiate this rhythm disturbance from pathologic VT to avoid potentially toxic antiarrhythmic agents. Patients should be followed until resolution to monitor cardiac function because a decline in cardiac function may rarely occur in patients with frequent ventricular ectopy [<a href="#rid46">46</a>]. Accelerated ventricular rhythm is thought to be due to enhanced automaticity of the myocardium or His-Purkinje fibers. Although typically benign, in the setting of metabolic disarray, ischemia, or myocardial disease, it may be a harbinger of more malignant ventricular arrhythmias [<a href="#rid46">46</a>].</p><p class="headingAnchor" id="H12"><span class="h3">Right ventricular outflow tract tachycardia</span><span class="headingEndMark"> — </span>One of the most common ventricular arrhythmias in young patients is RVOT tachycardia, a generally benign condition that may resolve spontaneously. Even in those in whom it persists, the arrhythmia burden often declines over time. The tachycardia is monomorphic with left bundle branch block QRS morphology and an inferior axis. There is often a late transition (after lead V3) in the precordial leads [<a href="#rid46">46</a>].</p><p>This rhythm disturbance is thought to be a cAMP-mediated triggered activity, and as such, it may be responsive to termination with vagal maneuvers, <a class="drug drug_pediatric" data-topicid="13258" href="/z/d/drug information/13258.html" rel="external">adenosine</a>, calcium channel blockers, and beta blockers. Rarely, RVOT tachycardia may be due to automaticity or reentry that may or may not be sensitive to <a class="drug drug_pediatric" data-topicid="12879" href="/z/d/drug information/12879.html" rel="external">verapamil</a>. It is characterized by relatively slow rates (140 to 190 beats per minute) with a monomorphic QRS pattern of left bundle branch block and an inferior axis.</p><p>Children with RVOT may be asymptomatic and present because of an incidental finding [<a href="#rid42">42</a>]. A retrospective review of 48 Canadian children with RVOT tachycardia who presented at a median age of 8.2 years showed that 41 of the 48 patients (82 percent) presented with an incidental finding of an irregular heart rhythm or abnormal ECG [<a href="#rid42">42</a>]. Seven patients were referred because of syncope or near syncope. Reported symptoms obtained from interviews of patients included abdominal pain, asthma-related complaints, fatigue, fever, limb pain, and rash. In other series, palpitations and near syncope were noted in ≥50 percent of patients [<a href="#rid46">46,47</a>]. RVOT tachycardia that is incessant and longstanding can result in arrhythmia-induced cardiomyopathy. Syncope is uncommon in RVOT tachycardia and should raise suspicion of another diagnosis or an associated cardiomyopathy [<a href="#rid46">46</a>].</p><p>Magnetic resonance imaging (MRI) may reveal subtle abnormalities of the right ventricle, including thinning of the ventricular free wall, fatty infiltration, and wall motion abnormalities [<a href="#rid42">42</a>]. In the previously mentioned Canadian study, 13 of the 25 patients studied by MRI had abnormalities of the right ventricle [<a href="#rid42">42</a>].</p><p>A major challenge for the clinician is to distinguish children with RVOT tachycardia from the more serious ARVC, discussed above, which has a high risk of sudden cardiac death. Rigorous diagnostic criteria must be employed before arriving at the diagnosis of ARVC as many patients with minor criteria have been inappropriately diagnosed with ARVC [<a href="#rid48">48</a>]. An incidental presentation and slow VT generally are more characteristic of patients with RVOT compared with those with ARVC. The VT associated with ARVC is usually due to reentry and not responsive to vagal maneuvers or <a class="drug drug_pediatric" data-topicid="13258" href="/z/d/drug information/13258.html" rel="external">adenosine</a> [<a href="#rid49">49</a>]. However, further diagnostic testing including MRI, EP testing, and/or signal-averaged ECG may further differentiate the two entities [<a href="#rid42">42</a>]. (See  <a class="medical medical_review" href="/z/d/html/4931.html" rel="external">"Arrhythmogenic right ventricular cardiomyopathy: Anatomy, histology, and clinical manifestations", section on 'RVOT tachycardia'</a>.)</p><p>Treatment for RVOT tachycardia is indicated for symptomatic patients and those rare patients who develop arrhythmia-induced cardiomyopathy [<a href="#rid50">50</a>]. Therapy includes antiarrhythmic agents and catheter ablation [<a href="#rid42">42</a>]. Catheter ablation has proven highly successful, and the application of novel mapping systems, noncontact, and electroanatomical techniques increase efficacy [<a href="#rid50">50</a>].</p><p>Prognosis for this condition is excellent, and there is no related mortality in patients with structurally and functionally normal hearts up to an 80-month follow-up period [<a href="#rid42">42,47</a>]. VT can originate from the left ventricular outflow tract and is similar to RVOT tachycardia in its clinical manifestations, prognosis, and management. In patients with left ventricular outflow tract tachycardia, the ECG demonstrates monomorphic VT with a right bundle branch block and inferior axis. (See  <a class="medical medical_review" href="/z/d/html/965.html" rel="external">"Ventricular tachycardia in the absence of apparent structural heart disease", section on 'Repetitive monomorphic VT'</a>.)</p><p class="headingAnchor" id="H13"><span class="h3">Idiopathic left ventricular tachycardia</span><span class="headingEndMark"> — </span>Idiopathic left VT (also referred to as left ventricular fascicular tachycardia, Belhassen tachycardia, or <a class="drug drug_pediatric" data-topicid="12879" href="/z/d/drug information/12879.html" rel="external">verapamil</a> sensitive tachycardia) is a benign VT. In affected patients, the ECG demonstrates a right bundle branch block with a superior or left axis.</p><p>Idiopathic left VT originates from the left posterior fascicle and occurs in the absence of structural disease, although it may be related to a false tendon that extends from the posteroinferior left ventricle to the septum.</p><p>The mechanism of VT is thought to be due to a reentry circuit in the vicinity of the left posterior fascicle. As a reentrant tachycardia, it can be initiated with atrial and ventricular pacing. The VT is sensitive to <a class="drug drug_pediatric" data-topicid="12879" href="/z/d/drug information/12879.html" rel="external">verapamil</a> and occasionally <a class="drug drug_pediatric" data-topicid="13258" href="/z/d/drug information/13258.html" rel="external">adenosine</a> but not vagal maneuvers. Although catheter ablation is an effective cure, even without therapy, this form of VT has a good prognosis with occasional spontaneous remissions and rare reports of tachycardia-induced cardiomyopathy [<a href="#rid46">46,51</a>]. (See  <a class="medical medical_review" href="/z/d/html/965.html" rel="external">"Ventricular tachycardia in the absence of apparent structural heart disease", section on 'Idiopathic left ventricular tachycardia'</a>.)</p><p>The application of noncontact mapping strategies to both RVOT tachycardia and idiopathic left VT has increased the ability to provide a cure for these problems in children, even when the tachycardia is not sustained [<a href="#rid52">52</a>].</p><p class="headingAnchor" id="H3880494317"><span class="h2">Arrhythmia-induced cardiomyopathy</span><span class="headingEndMark"> — </span>Idiopathic VT and, more commonly, frequent PVCs can lead to left ventricular dysfunction in patients without structural heart disease and can exacerbate cardiomyopathy in patients with heart disease. The mechanism of PVC-mediated cardiomyopathy is not fully understood in adult patients, and less is known about this in pediatric patients. Potential mechanisms include ventricular dyssynchrony especially related to a left bundle branch block morphology, abnormal calcium handling from the short coupling intervals, and abnormal ventricular filling from the pause after the ectopic beat [<a href="#rid53">53</a>]. In a study involving 72 children with ventricular ectopy and asymptomatic VT, six patients (8 percent) had left ventricular dysfunction (defined as a shortening fraction of ≤28 percent) at presentation [<a href="#rid54">54</a>]. Patients with left ventricular dysfunction had a higher burden of ectopy, higher number of couplets, and higher prevalence of VT. Following treatment of the arrhythmia (with medication [n = 2] or ablation [n = 5]), left ventricular function normalized in five of six patients. This small pediatric study suggests that the left ventricular dysfunction is reversible with termination of culprit arrhythmia, a finding that is consistent with clinical studies in adults and animal studies [<a href="#rid53">53</a>]. (See  <a class="medical medical_review" href="/z/d/html/1062.html" rel="external">"Arrhythmia-induced cardiomyopathy"</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Importance</strong> – Wide QRS tachycardia may be due to ventricular tachycardia (VT), supraventricular tachycardia (SVT) with aberrant conduction, or atrioventricular reentrant tachycardia (AVRT) with an accessory pathway. Children with wide QRS complex tachycardia may present with hemodynamic instability, and if not urgently treated, serious morbidity or death may occur. (See <a class="local">'Introduction'</a> above and  <a class="medical medical_review" href="/z/d/html/5758.html" rel="external">"Management and evaluation of wide QRS complex tachycardia in children", section on 'Initial management'</a>.)</p><p></p><p class="bulletIndent1">SVT is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/5783.html" rel="external">"Clinical features and diagnosis of supraventricular tachycardia (SVT) in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>VT in congenital heart disease</strong> – VT is often seen as a late surgical complication in patients with congenital heart disease (CHD) and is associated with a significant increase in mortality and serious morbidity. (See <a class="local">'Congenital heart disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetic causes of VT</strong> – VT is associated with inherited disorders that affect the cardiac muscle and/or function and can present with life-threatening ventricular arrhythmias or a history of unexplained death in a young family member. These include channelopathies and inherited causes of cardiomyopathy (see <a class="local">'Genetic disorders'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Congenital long QT syndrome (LQTS) (see  <a class="medical medical_review" href="/z/d/html/1009.html" rel="external">"Congenital long QT syndrome: Pathophysiology and genetics"</a> and  <a class="medical medical_review" href="/z/d/html/1036.html" rel="external">"Congenital long QT syndrome: Epidemiology and clinical manifestations"</a> and  <a class="medical medical_review" href="/z/d/html/1053.html" rel="external">"Congenital long QT syndrome: Diagnosis"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Brugada syndrome (see  <a class="medical medical_review" href="/z/d/html/1020.html" rel="external">"Brugada syndrome: Epidemiology and pathogenesis"</a> and  <a class="medical medical_review" href="/z/d/html/106759.html" rel="external">"Brugada syndrome: Clinical presentation, diagnosis, and evaluation"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Catecholaminergic polymorphic VT (CPVT) (see  <a class="medical medical_review" href="/z/d/html/916.html" rel="external">"Catecholaminergic polymorphic ventricular tachycardia"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hypertrophic cardiomyopathy (see  <a class="medical medical_review" href="/z/d/html/4951.html" rel="external">"Hypertrophic cardiomyopathy in children: Clinical manifestations and diagnosis"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Arrhythmogenic cardiomyopathy (see  <a class="medical medical_review" href="/z/d/html/4929.html" rel="external">"Arrhythmogenic right ventricular cardiomyopathy: Pathogenesis and genetics"</a> and  <a class="medical medical_review" href="/z/d/html/4931.html" rel="external">"Arrhythmogenic right ventricular cardiomyopathy: Anatomy, histology, and clinical manifestations"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Duchenne muscular dystrophy (see  <a class="medical medical_review" href="/z/d/html/6149.html" rel="external">"Duchenne and Becker muscular dystrophy: Clinical features and diagnosis", section on 'Cardiomyopathy'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Barth syndrome (see  <a class="medical medical_review" href="/z/d/html/4912.html" rel="external">"Inherited syndromes associated with cardiac disease", section on 'Barth syndrome'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>VT in acquired heart disease</strong> – Acquired heart diseases associated with VT include myocarditis and acquired QTc prolongation. In contrast with adults, coronary artery disease is a rare cause of VT in children. (See <a class="local">'Acquired heart disease'</a> above and  <a class="medical medical_review" href="/z/d/html/5755.html" rel="external">"Clinical manifestations and diagnosis of myocarditis in children"</a> and  <a class="medical medical_review" href="/z/d/html/1043.html" rel="external">"Acquired long QT syndrome: Definitions, pathophysiology, and causes"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Idiopathic causes</strong> – Idiopathic causes of VT include accelerated ventricular rhythm, right ventricular outflow tract (RVOT) tachycardia, and idiopathic left VT. These occur primarily in infants and young children with structurally normal hearts, and they generally have a benign course; however, these diagnoses are only made after other more serious causes of VT are excluded. (See <a class="local">'Idiopathic causes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Arrhythmia-induced cardiomyopathy</strong> – Idiopathic VT and frequent premature ventricular contractions (PVCs) can lead to left ventricular dysfunction in patients without structural heart disease and can exacerbate cardiomyopathy in patients with heart disease. In most cases, left ventricular dysfunction is reversible with termination of culprit arrhythmia. (See <a class="local">'Arrhythmia-induced cardiomyopathy'</a> above and  <a class="medical medical_review" href="/z/d/html/1062.html" rel="external">"Arrhythmia-induced cardiomyopathy"</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Viitasalo MT, Kala R, Eisalo A. Ambulatory electrocardiographic recording in endurance athletes. Br Heart J 1982; 47:213.</a></li><li><a class="nounderline abstract_t">Dickinson DF, Scott O. Ambulatory electrocardiographic monitoring in 100 healthy teenage boys. Br Heart J 1984; 51:179.</a></li><li><a class="nounderline abstract_t">Roggen A, Pavlovic M, Pfammatter JP. Frequency of spontaneous ventricular tachycardia in a pediatric population. Am J Cardiol 2008; 101:852.</a></li><li><a class="nounderline abstract_t">Iwamoto M, Niimura I, Shibata T, et al. Long-term course and clinical characteristics of ventricular tachycardia detected in children by school-based heart disease screening. Circ J 2005; 69:273.</a></li><li><a class="nounderline abstract_t">Walsh EP, Cecchin F. Arrhythmias in adult patients with congenital heart disease. Circulation 2007; 115:534.</a></li><li><a class="nounderline abstract_t">Walsh EP, Rockenmacher S, Keane JF, et al. Late results in patients with tetralogy of Fallot repaired during infancy. Circulation 1988; 77:1062.</a></li><li><a class="nounderline abstract_t">Keane JF, Driscoll DJ, Gersony WM, et al. Second natural history study of congenital heart defects. Results of treatment of patients with aortic valvar stenosis. Circulation 1993; 87:I16.</a></li><li><a class="nounderline abstract_t">Houyel L, Vaksmann G, Fournier A, Davignon A. Ventricular arrhythmias after correction of ventricular septal defects: importance of surgical approach. J Am Coll Cardiol 1990; 16:1224.</a></li><li><a class="nounderline abstract_t">Khairy P, Landzberg MJ, Gatzoulis MA, et al. Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study. Circulation 2004; 109:1994.</a></li><li><a class="nounderline abstract_t">Khairy P, Van Hare GF, Balaji S, et al. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm 2014; 11:e102.</a></li><li><a class="nounderline abstract_t">Walsh EP. Sudden death in adult congenital heart disease: risk stratification in 2014. Heart Rhythm 2014; 11:1735.</a></li><li><a class="nounderline abstract_t">Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000; 356:975.</a></li><li><a class="nounderline abstract_t">Deanfield JE, McKenna WJ, Presbitero P, et al. Ventricular arrhythmia in unrepaired and repaired tetralogy of Fallot. Relation to age, timing of repair, and haemodynamic status. Br Heart J 1984; 52:77.</a></li><li><a class="nounderline abstract_t">Bricker JT. Sudden death and tetralogy of Fallot. Risks, markers, and causes. Circulation 1995; 92:158.</a></li><li><a class="nounderline abstract_t">Ghai A, Silversides C, Harris L, et al. Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol 2002; 40:1675.</a></li><li><a class="nounderline abstract_t">Berul CI, Hill SL, Geggel RL, et al. Electrocardiographic markers of late sudden death risk in postoperative tetralogy of Fallot children. J Cardiovasc Electrophysiol 1997; 8:1349.</a></li><li><a class="nounderline abstract_t">Gatzoulis MA, Till JA, Redington AN. Depolarization-repolarization inhomogeneity after repair of tetralogy of Fallot. The substrate for malignant ventricular tachycardia? Circulation 1997; 95:401.</a></li><li><a class="nounderline abstract_t">Khairy P, Marelli AJ. Clinical use of electrocardiography in adults with congenital heart disease. Circulation 2007; 116:2734.</a></li><li><a class="nounderline abstract_t">Geva T, Mulder B, Gauvreau K, et al. Preoperative Predictors of Death and Sustained Ventricular Tachycardia After Pulmonary Valve Replacement in Patients With Repaired Tetralogy of Fallot Enrolled in the INDICATOR Cohort. Circulation 2018; 138:2106.</a></li><li><a class="nounderline abstract_t">Splawski I, Timothy KW, Sharpe LM, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004; 119:19.</a></li><li><a class="nounderline abstract_t">Plaster NM, Tawil R, Tristani-Firouzi M, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001; 105:511.</a></li><li><a class="nounderline abstract_t">Tester DJ, Wong LCH, Chanana P, et al. Cardiac Genetic Predisposition in Sudden Infant Death Syndrome. J Am Coll Cardiol 2018; 71:1217.</a></li><li><a class="nounderline abstract_t">Zipes DP, Ackerman MJ, Estes NA 3rd, et al. Task Force 7: arrhythmias. J Am Coll Cardiol 2005; 45:1354.</a></li><li class="breakAll">Exercise in Genetic Cardiovascular Conditions (LIVE-HCM/LQT) Study Record. Available at: https://clinicaltrials.gov/ct2/show/NCT02549664 (Accessed on September 22, 2016).</li><li><a class="nounderline abstract_t">Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20:1391.</a></li><li><a class="nounderline abstract_t">Bezzina CR, Lahrouchi N, Priori SG. Genetics of sudden cardiac death. Circ Res 2015; 116:1919.</a></li><li><a class="nounderline abstract_t">Tester DJ, Dura M, Carturan E, et al. A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors. Heart Rhythm 2007; 4:733.</a></li><li><a class="nounderline abstract_t">Nyegaard M, Overgaard MT, Søndergaard MT, et al. Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. Am J Hum Genet 2012; 91:703.</a></li><li><a class="nounderline abstract_t">Marsman RF, Barc J, Beekman L, et al. A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence. J Am Coll Cardiol 2014; 63:259.</a></li><li><a class="nounderline abstract_t">Leren IS, Saberniak J, Majid E, et al. Nadolol decreases the incidence and severity of ventricular arrythmias during exercise testing compared with B1-selective b-blockers in patients with Cathecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2016; 12:433.</a></li><li><a class="nounderline abstract_t">De Ferrari GM, Dusi V, Spazzolini C, et al. Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation. Circulation 2015; 131:2185.</a></li><li><a class="nounderline abstract_t">Zaidi A, Ghani S, Sharma R, et al. Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin. Circulation 2013; 127:1783.</a></li><li><a class="nounderline abstract_t">Zaidi A, Sheikh N, Jongman JK, et al. Clinical Differentiation Between Physiological Remodeling and Arrhythmogenic Right Ventricular Cardiomyopathy in Athletes With Marked Electrocardiographic Repolarization Anomalies. J Am Coll Cardiol 2015; 65:2702.</a></li><li><a class="nounderline abstract_t">Chenard AA, Becane HM, Tertrain F, et al. Ventricular arrhythmia in Duchenne muscular dystrophy: prevalence, significance and prognosis. Neuromuscul Disord 1993; 3:201.</a></li><li><a class="nounderline abstract_t">Connuck DM, Sleeper LA, Colan SD, et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J 2008; 155:998.</a></li><li><a class="nounderline abstract_t">Spencer CT, Byrne BJ, Gewitz MH, et al. Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome. Pediatr Cardiol 2005; 26:632.</a></li><li><a class="nounderline abstract_t">Villa AD, Sammut E, Nair A, et al. Coronary artery anomalies overview: The normal and the abnormal. World J Radiol 2016; 8:537.</a></li><li><a class="nounderline abstract_t">Tse G, Yeo JM, Chan YW, et al. What Is the Arrhythmic Substrate in Viral Myocarditis? Insights from Clinical and Animal Studies. Front Physiol 2016; 7:308.</a></li><li><a class="nounderline abstract_t">Miyake CY, Del Nido PJ, Alexander ME, et al. Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia. J Am Coll Cardiol 2011; 58:1903.</a></li><li><a class="nounderline abstract_t">Carreon CK, Sanders SP, Perez-Atayde AR, et al. Interdigitating Myocardial Tongues in Pediatric Cardiac Fibromas: Plausible Substrate for Ventricular Tachycardia and Cardiac Arrest. JACC Clin Electrophysiol 2019; 5:563.</a></li><li class="breakAll">Grimm W, Marchlinski FE. Accelerated idioventricular rhythm: Bidirectional ventricular tachycardia.. In: Cardiac Electrophysiology: From Cell to Bedside, 4th Ed, Zipes DPJ, Jalife J (Eds), Philadelphia, PA 2004. p.700.</li><li><a class="nounderline abstract_t">Harris KC, Potts JE, Fournier A, et al. Right ventricular outflow tract tachycardia in children. J Pediatr 2006; 149:822.</a></li><li><a class="nounderline abstract_t">Davis AM, Gow RM, McCrindle BW, Hamilton RM. Clinical spectrum, therapeutic management, and follow-up of ventricular tachycardia in infants and young children. Am Heart J 1996; 131:186.</a></li><li><a class="nounderline abstract_t">Reynolds JL, Pickoff AS. Accelerated ventricular rhythm in children: a review and report of a case with congenital heart disease. Pediatr Cardiol 2001; 22:23.</a></li><li><a class="nounderline abstract_t">Van Hare GF, Stanger P. Ventricular tachycardia and accelerated ventricular rhythm presenting in the first month of life. Am J Cardiol 1991; 67:42.</a></li><li><a class="nounderline abstract_t">Crosson JE, Callans DJ, Bradley DJ, et al. PACES/HRS expert consensus statement on the evaluation and management of ventricular arrhythmias in the child with a structurally normal heart. Heart Rhythm 2014; 11:e55.</a></li><li><a class="nounderline abstract_t">Wang S, Zhu W, Hamilton RM, et al. Diagnosis-specific characteristics of ventricular tachycardia in children with structurally normal hearts. Heart Rhythm 2010; 7:1725.</a></li><li><a class="nounderline abstract_t">Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010; 121:1533.</a></li><li><a class="nounderline abstract_t">Sticherling C, Zabel M. Arrhythmogenic right ventricular dysplasia presenting as right ventricular outflow tract tachycardia. Europace 2005; 7:345.</a></li><li><a class="nounderline abstract_t">Paul T, Blaufox AT, Saul JP. Non-contact mapping and ablation of tachycardia originating in the right ventricular outflow tract. Cardiol Young 2002; 12:294.</a></li><li><a class="nounderline abstract_t">Ohe T, Aihara N, Kamakura S, et al. Long-term outcome of verapamil-sensitive sustained left ventricular tachycardia in patients without structural heart disease. J Am Coll Cardiol 1995; 25:54.</a></li><li><a class="nounderline abstract_t">Schneider HE, Kriebel T, Jung K, et al. Catheter ablation of idiopathic left and right ventricular tachycardias in the pediatric population using noncontact mapping. Heart Rhythm 2010; 7:731.</a></li><li><a class="nounderline abstract_t">Gopinathannair R, Etheridge SP, Marchlinski FE, et al. Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management. J Am Coll Cardiol 2015; 66:1714.</a></li><li><a class="nounderline abstract_t">Bertels RA, Harteveld LM, Filippini LH, et al. Left ventricular dysfunction is associated with frequent premature ventricular complexes and asymptomatic ventricular tachycardia in children. Europace 2016.</a></li></ol></div><div id="topicVersionRevision">Topic 5786 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7059398" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Ambulatory electrocardiographic recording in endurance athletes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6197983" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Ambulatory electrocardiographic monitoring in 100 healthy teenage boys.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18328852" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Frequency of spontaneous ventricular tachycardia in a pediatric population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15731530" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Long-term course and clinical characteristics of ventricular tachycardia detected in children by school-based heart disease screening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17261672" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Arrhythmias in adult patients with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3359587" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Late results in patients with tetralogy of Fallot repaired during infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8425319" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Second natural history study of congenital heart defects. Results of treatment of patients with aortic valvar stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2229771" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Ventricular arrhythmias after correction of ventricular septal defects: importance of surgical approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15051640" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24814377" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25046858" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Sudden death in adult congenital heart disease: risk stratification in 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11041398" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6743425" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Ventricular arrhythmia in unrepaired and repaired tetralogy of Fallot. Relation to age, timing of repair, and haemodynamic status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7541319" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Sudden death and tetralogy of Fallot. Risks, markers, and causes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12427422" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9436772" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Electrocardiographic markers of late sudden death risk in postoperative tetralogy of Fallot children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9008456" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Depolarization-repolarization inhomogeneity after repair of tetralogy of Fallot. The substrate for malignant ventricular tachycardia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18056539" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Clinical use of electrocardiography in adults with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30030416" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Preoperative Predictors of Death and Sustained Ventricular Tachycardia After Pulmonary Valve Replacement in Patients With Repaired Tetralogy of Fallot Enrolled in the INDICATOR Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15454078" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11371347" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29544605" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Cardiac Genetic Predisposition in Sudden Infant Death Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15837287" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Task Force 7: arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15837287" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Task Force 7: arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1309182" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26044248" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Genetics of sudden cardiac death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17556193" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23040497" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24076290" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Nadolol decreases the incidence and severity of ventricular arrythmias during exercise testing compared with B1-selective b-blockers in patients with Cathecholaminergic polymorphic ventricular tachycardia</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26019152" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23538381" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26112193" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Clinical Differentiation Between Physiological Remodeling and Arrhythmogenic Right Ventricular Cardiomyopathy in Athletes With Marked Electrocardiographic Repolarization Anomalies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7691292" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Ventricular arrhythmia in Duchenne muscular dystrophy: prevalence, significance and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18513510" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16235007" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27358682" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Coronary artery anomalies overview: The normal and the abnormal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27493633" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : What Is the Arrhythmic Substrate in Viral Myocarditis? Insights from Clinical and Animal Studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22018302" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31122378" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Interdigitating Myocardial Tongues in Pediatric Cardiac Fibromas: Plausible Substrate for Ventricular Tachycardia and Cardiac Arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31122378" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Interdigitating Myocardial Tongues in Pediatric Cardiac Fibromas: Plausible Substrate for Ventricular Tachycardia and Cardiac Arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17137900" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Right ventricular outflow tract tachycardia in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8554007" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Clinical spectrum, therapeutic management, and follow-up of ventricular tachycardia in infants and young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11123122" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Accelerated ventricular rhythm in children: a review and report of a case with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1986502" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Ventricular tachycardia and accelerated ventricular rhythm presenting in the first month of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24814375" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : PACES/HRS expert consensus statement on the evaluation and management of ventricular arrhythmias in the child with a structurally normal heart.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20691281" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Diagnosis-specific characteristics of ventricular tachycardia in children with structurally normal hearts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20172911" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15944092" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Arrhythmogenic right ventricular dysplasia presenting as right ventricular outflow tract tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12365181" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Non-contact mapping and ablation of tachycardia originating in the right ventricular outflow tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7798526" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Long-term outcome of verapamil-sensitive sustained left ventricular tachycardia in patients without structural heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20193776" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Catheter ablation of idiopathic left and right ventricular tachycardias in the pediatric population using noncontact mapping.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26449143" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27247014" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Left ventricular dysfunction is associated with frequent premature ventricular complexes and asymptomatic ventricular tachycardia in children.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
